Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00869440 · ClinicalTrials.gov registry record · Phase 2
Dose-Finding Safety Study Evaluating Remimazolam (CNS 7056) in Patients Undergoing Diagnostic Upper GI Endoscopy
A Phase 2 study, sponsored by Paion UK.
- Completed
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
NCT00869440 is a Phase 2 study that has completed, run by Paion UK. The registered enrollment target is 100 participants.
The verdict
NCT00869440, a Phase 2 study, has completed, sponsored by Paion UK.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this study was to assess the safety and efficacy of CNS 7056 as a procedural sedative at three dose levels compared to midazolam during a diagnostic upper GI endoscopy.
Interventions
- DRUG Midazolam
- DRUG CNS 7056
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2009-03 |
| Est. Completion | 2009-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00869440
The ClinicalTrials.gov registry entry for NCT00869440 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Paion UK, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Midazolam is the first listed.
NCT00869440 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00869440 about?
NCT00869440 is a clinical study titled "Dose-Finding Safety Study Evaluating Remimazolam (CNS 7056) in Patients Undergoing Diagnostic Upper GI Endoscopy". The purpose of this study was to assess the safety and efficacy of CNS 7056 as a procedural sedative at three dose levels compared to midazolam during a diagnostic upper GI endoscopy.
What is the current status of trial NCT00869440?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2009-03. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00869440?
The interventions under investigation include: Midazolam (DRUG), CNS 7056 (DRUG).
Who is sponsoring clinical trial NCT00869440?
This trial is sponsored by Paion UK, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.